Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.109 (
AST
)
6,066
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of various proteases (trypsin, chymotrypsin, subtilisin, protease 401, and
thermolysin
) on the mitochondrial isoenzyme (m-
AST
) and cytoplasmic isoenzyme (c-
AST
) of human and swine aspartate aminotransferase (
AST
;EC 2.6.1.1) was evaluated. All procedures including the reaction with proteases and the subsequent determination of the
AST
activity were carried out in an automatic analyzer. The mammalian c-
AST
was efficiently inactivated by chymotrypsin, subtilisin and protease 401 while m-
AST
activity decreased very slowly with these proteases. Thermolysin and trypsin showed much less effect on c-
AST
activity. Especially, chymotrypsin at concentrations of 0.5-1.0 g/L inactivated human c-
AST
almost completely but showed no detectable inactivating effect on m-
AST
. Thus chymotrypsin appears to be the most suitable protease for the differential determination of
AST
isoenzymes in human serum. Further studies on the effects of proteases with
AST
from other species showed that Escherichia coli
AST
resembled mammalian m-
AST
while Pseudomonas
AST
resembled c-
AST
.
...
PMID:Determination of human aspartate aminotransferase isoenzymes by their differential sensitivity to proteases. 306 46